Value Viewpoint – recent developments in US healthcare value and access with Kimberly Westrich: March – April 2024

30 Apr 2024

Written by Kimberly Westrich (National Pharmaceutical Council)

Guest columns Health economics Health policy Health technology assessment ISPOR Patient engagement Value assessment

Kimberly Westrich (Chief Strategy Officer, National Pharmaceutical Council) shares her highlights in US healthcare value and access from March and April 2024. What happened over these months that you were expecting? In April, I attended the Academy of Managed Care Pharmacy (AMCP) Annual Meeting, where I presented research and engaged in insightful policy conversations with a wide range of healthcare stakeholders, including the next generation of managed care researchers. I thoroughly enjoyed Eleanor Perfetto's (University of Maryland) and Sarah Emond’s (ICER) session on effective patient engagement in pharmaceutical value assessments, which was the ideal companion to my session on a...